本期内容提示:
1、一大波核心仓位出现建仓机会,优先考虑哪些?
2、又一只有翻倍潜力的成长股临近理想建仓区;
3、$Rxi Pharmaceuticals Corp(PHIO)$ 数据不错,可否追涨?
$恒瑞医药(SH600276)$ $华东医药(SZ000963)$查看全文
Replix锐璞美股2021-03-01 21:16
$Phio Pharmaceuticals(PHIO)$ PHIO PHARMACEUTICALS AND AGONOX, INC. ANNOUNCE COLLABORATION ON CLINICAL DEVELOPMENT OF NOVEL T CELL-BASED CANCER IMMUNOTHERAPIES
Under the terms of the collaboration agreement, AgonOx will receive financial support for the clinical trial from...查看全文
Replix锐璞美股2021-02-18 14:08
$Phio Pharmaceuticals(PHIO)$ 公司增发完毕,看看是否能翻身。
$基因进化ETF-ARK(ARKG)$ $富途控股(FUTU)$查看全文
$Phio Pharmaceuticals(PHIO)$ 8-K Current report, items 1.01, 3.02, and 9.01 Accession Number: 0001683168-21-000600 Act: 34 Size: 348 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001683168-21-000593 Act: 33 Size: 358 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-21-023252 Act: 34 Size: 59 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ D Notice of Exempt Offering of Securities, item 06b Accession Number: 0001683168-21-000554 Act: 33 Size: 13 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ 424B2 Prospectus [Rule 424(b)(2)] Accession Number: 0001683168-21-000437 Act: 33 Size: 176 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-21-000508 Act: 33 Size: 1 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ S-3/A [Amend] Registration statement under Securities Act of 1933 Accession Number: 0001683168-21-000395 Act: 33 Size: 60 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001683168-21-000315 Act: 33 Size: 280 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001213900-21-005111 Act: 34 Size: 62 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ 8-K Current report, items 1.01, 3.02, and 9.01 Accession Number: 0001683168-21-000249 Act: 34 Size: 617 KB 网页链接